Atmosphere-ph.ru

Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru

ИНТЕРНЕТ-МАГАЗИН

Телефон издательства

Лечебное дело
2020 / N 1

Депрессия и посттравматическое стрессовое расстройство при новой коронавирусной инфекции
Н.В. Пизова, А.В. Пизов

Список литературы

1. Wang C. A novel coronavirus outbreak of global health concern. The Lancet 2020 Feb;395(10223):470-3.
2. Hawryluck L, Gold WL, Robinson S, Pogorski S, Galea S, Styra R. SARS control and psychological effects of quarantine, Toronto, Canada. Emerging Infectious Diseases 2004 Jul;10(7):1206-12.
3. Arciniegas DB, Anderson CA. Viral encephalitis: neuropsychiatric and neurobehavioral aspects. Current Psychiatry Reports 2004 Oct;6(5):372-9.
4. Dubé B, Benton T, Cruess DG, Evans DL. Neuropsychiatric manifestations of HIV infection and AIDS. Journal of Psychiatry & Neuroscience 2005 Jul;30(4):237-46.
5. Hinkin CH, Castellon SA, Atkinson JH, Goodkin K. Neuropsychiatric aspects of HIV infection among older adults. Journal of Clinical Epidemiology 2001 Dec;54(Suppl 1):S44-52.
6. Okusaga O, Yolken RH, Langenberg P, Lapidus M, Arling TA, Dickerson FB, Scrandis DA, Severance E, Cabassa JA, Balis T, Postolache TT. Association of seropositivity for influenza and coronaviruses with history of mood disorders and suicide attempts. Journal of Affective Disorders 2011 Apr;130(1):220-5.
7. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N, Bi Y, Ma X, Zhan F, Wang L, Hu T, Zhou H, Hu Z, Zhou W, Zhao L, Chen J, Meng Y, Wang J, Lin Y, Yuan J, Xie Z, Ma J, Liu WJ, Wang D, Xu W, Holmes EC, Gao GF, Wu G, Chen W, Shi W, Tan W. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet 2020 Feb;395(10224):565-74.
8. Desforges M, Le Coupanec A, Dubeau P, Bourgouin A, Lajoie L, Dubé B, Talbot PJ. Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? Viruses 2020 Jan;12:14.
9. Bohmwald K, Gálvez NMS, Ríos M, Kalergis AM. Neurologic alterations due to respiratory virus infections. Frontiers in Cellular Neuroscience 2018 Oct;12:386.
10. World Health Organization. 2019 novel coronavirus (2019nCoV): strategic preparedness and response plan. Draft, 2020 Feb 03. Geneva, Switzerland: WHO; 2020. 28 p. Available from: https://www.who.int/docs/default-source/coronaviruse/srp-04022020.pdf Accessed 2020 Jun 25.
11. World Health Organization. Mental health and psychosocial considerations during the COVID-19 outbreak. March 18, 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/mental-health-considerations.pdf Accessed 2020 Jun 25.
12. Zhao Q, Hu C, Feng R, Yang Y. Anxiety, depression and somatic symptoms in COVID-19 patients. Chinese Journal of Neurology 2020;53:E003.
13. Cheng SKW, Tsang JSK, Ku KH, Wong CW, Ng YK. Psychiatric complications in patients with severe acute respiratory syndrome (SARS) during the acute treatment phase: a series of 10 cases. The British Journal of Psychiatry 2004 Apr;184:359-60.
14. Chua SE, Cheung V, McAlonan GM, Cheung C, Wong JWS, Cheung EPT, Chan MTY, Wong TKW, Choy KM, Chu CM, Lee PWH, Tsang KWT. Stress and psychological impact on SARS patients during the outbreak. The Canadian Journal of Psychiatry 2004 Jun;49(6):385-90.
15. Cheng SKW, Wong CW, Tsang J, Wong KC. Psychological distress and negative appraisals in survivors of severe acute respiratory syndrome (SARS). Psychological Medicine 2004 Oct;34(7):1187-95.
16. Wu KK, Chan SK, Ma TM. Posttraumatic stress, anxiety, and depression in survivors of severe acute respiratory syndrome (SARS). Journal of Traumatic Stress 2005 Feb;18(1):39-42.
17. Lee AM, Wong J, McAllonan GM, Cheung V, Cheung C, Sham PC, Chu CM, Wong PC, Tsang K, Chua SE. Stress and psychological distress among SARS survivors 1 year after the outbreak. The Canadian Journal of Psychiatry 2007 Apr;52(4):233-40.
18. Mak IWC, Chu CM, Pan PC, Yiu MGC, Chan VL. Long-term psychiatric morbidities among SARS survivors. General Hospital Psychiatry 2009 Jul-Aug;31(4):318-26.
19. Lam MHB, Wing YK, Yu MWM, Leung CM, Ma RCW, Kong APS, So WY, Fong SYY, Lam SP. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Archives of Internal Medicine 2009 Dec;169(22):2142-7.
20. Lin CY, Peng YC, Chang J, Chan CH, Yang DY. The psychological effect of severe acute respiratory syndrome on emergency department staff. Emergency Medicine Journal 2007 Jan;24(1):12-7.
21. Verma S, Mythili S, Chan YH, Deslypere JP, Teo EK, Chong SA. Post-SARS psychological morbidity and stigma among general practitioners and traditional Chinese medicine practitioners in Singapore. Annals of the Academy of Medicine, Singapore 2004 Nov;33(6):743-8.
22. Lancee WJ, Maunder RG, Goldbloom DS; Coauthors for the Impact of SARS study. Prevalence of psychiatric disorders among Toronto hospital workers one to two years after the SARS outbreak. Psychiatric Services (Washington, D.C.) 2008 Jan;59(1):91-5.
23. Liu X, Kakade M, Fuller CJ, Fan B, Fang Y, Kong J, Guan Z, Wu P. Depression after exposure to stressful events: lessons learned from the severe acute respiratory syndrome epidemic. Comprehensive Psychiatry 2012 Jan;53(1):15-23.
24. Ko CH, Yen CF, Yen JY, Yang MJ. Psychosocial impact among the public of the severe acute respiratory syndrome epidemic in Taiwan. Psychiatry and Clinical Neurosciences 2006 Aug;60(4):397-403.
25. Besedovsky H, Rey AD, Sorkin E, Dinarello CA. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science (New York, N.Y.) 1986 Aug;233(4764):652-4.
26. Besedovsky HO, Rey AD, Klusman I, Furukawa H, Monge AG, Kabiersch A. Cytokines as modulators of the hypothalamus-pituitary-adrenal axis. The Journal of Steroid Biochemistry and Molecular Biology 1991;40(4-6):613-8.
27. Wang J, Dunn AJ. Mouse interleukin-6 stimulates the HPA axis and increases brain tryptophan and serotonin metabolism. Neurochemistry International 1998 Aug;33(2):143-54.
28. Licinio J, Wong ML. The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection. Molecular Psychiatry 1999 Jul;4(4):317-27.
29. Capuron L, Fornwalt FB, Knight BT, Harvey PD, Ninan PT, Miller AH. Does cytokine-induced depression differ from idiopathic major depression in medically healthy individuals? Journal of Affective Disorders 2009 Dec;119(1-5):181-5.
30. Vollmer-Conna U. Acute sickness behaviour: an immune system-to-brain communication? Psychological Medicine 2001 Jul;31(5):761-7.
31. Wichers M, Maes M. Psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans. International Journal of Neuropsychopharmacology 2002 Dec;5(4):375-88.
32. Dursun SM, Blackburn JR, Kutcher SP. An exploratory approach to the serotonergic hypothesis of depression: bridging the synaptic gap. Medical Hypotheses 2001 Feb;56(2):235-43.
33. Arbour N, Day R, Newcombe J, Talbot PJ. Neuroinvasion by human respiratory coronaviruses. Journal of Virology 2000 Oct;74(19):8913-21.
34. Dessau RB, Lisby G, Frederiksen JL. Coronaviruses in brain tissue from patients with multiple sclerosis. Acta Neuropathology 2001;101(6):601-4.
35. Fujimoto S, Kobayashi M, Uemura O, Iwasa M, Ando T, Katoh T, Nakamura C, Maki N, Togari H, Wada Y. PCR on cerebrospinal fluid to show influenza-associated acute encephalopathy or encephalitis. The Lancet 1998 Sep;352(9131):873-5.
36. Xu J, Zhong S, Liu J, Li L, Li Y, Wu X, Li Z, Deng P, Zhang J, Zhong N, Ding Y, Jiang Y. Detection of severe acute respiratory syndrome corona virus in the brain: potential role of the chemokine migration in pathogenesis. Clinical Infectious Disease 2005 Oct;41(8):1089-96.
37. Yeh A, Arlene C, Cohen ME, Duffner PK, Faden H. Detection of corona virus in the central nervous system of a child with acute disseminated encephalomyelitis. Pediatrics 2004 Jan;113(1 Pt 1):e73-6.
38. Vindegaard N, Benros ME. COVID-19 pandemic and mental health consequences: systematic review of the current evidence. Brain, Behavioral, and Immunity 2020 May 30. doi: 10.1016/j.bbi.2020.05.048. Epub ahead of print.
39. Bo HX, Li W, Yang Y, Wang Y, Zhang Q, Cheung T, Wu X, Xiang YT. Posttraumatic stress symptoms and attitude toward crisis mental health services among clinically stable patients with COVID-19 in China. Psychological Medicine 2020 Mar 27;1-2. doi: 10.1017/S0033291720000999. Online ahead of print.
40. Zhang J, Lu H, Zeng H, Zhang S, Du Q, Jiang T, Du B. The differential psychological distress of populations affected by the COVID-19 pandemic. Brain, Behavior, and Immunity 2020 Jul;87:49-50.
41. Horton R. Offline: 2019-nCoV – “A desperate plea”. The Lancet 2020 Feb;395:400.
42. Wang C, Pan R, Wan X, Tan Y, Xu L, Ho CS, Ho RC. Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China. International Journal of Environmental Research and Public Health 2020 Mar;17(5):1729.
43. Huang Y, Zhao N. Generalized anxiety disorder, depressive symptoms and sleep quality during COVID-19 outbreak in China: a web-based cross-sectional survey. Psychiatry Research 2020 Jun;288:112954.
44. Su TP, Lien TC, Yang CY, Su YL, Wang JH, Tsai SL, Yin JC. Prevalence of psychiatric morbidity and psychological adaptation of the nurses in a structured SARS Caring Unit during outbreak: a prospective and periodic assessment study in Taiwan. Journal of Psychiatric Research 2007 Jan-Feb;41(1-2):119-30.
45. Hao F, Tan W, Jiang L, Zhang L, Zhao X, Zou Y, Hu Y, Luo X, Jiang X, McIntyre R.S, Tran B, Sun J, Zhang Z, Ho R, Ho C, Tam W. Do psychiatric patients experience more psychiatric symptoms during COVID-19 pandemic and lockdown? A case-control study with service and research implications for immunopsychiatry. Brain, Behavior and Immunity 2020 Apr;87:100-6.
46. Zhu J, Sun L, Zhang L, Wang H, Fan A, Yang B, Li W, Xiao S. Prevalence and influencing factors of anxiety and depression symptoms in the first-line medical staff fighting against COVID-19 in Gansu. Frontiers in Psychiatry 2020;11:386.
47. Zhang WR, Wang K, Yin L, Zhao WF, Xue Q, Peng M, Min BQ, Tian Q, Leng HX, Du JL, Chang HY, Li W, Shangguan FF, Yan TY, Dong HQ, Han Y, Wang YP, Cosci F, Wang HX. Mental health and psychosocial problems of medical health workers during the COVID-19 epidemic in China. Psychotherapy and Psychosomatics 2020 Apr 9;1-9. doi: 10.1159/000507639. Online ahead of print.
48. Wang G, Zhang Y, Zhao J, Zhang J, Jiang F. Mitigate the effects of home confinement on children during the COVID-19 outbreak. The Lancet 2020 Mar;395(10228):945-7.
49. Ghosh R, Dubey MJ, Chatterjee S, Dubey S. Impact of COVID-19 on children: special focus on psychosocial aspect. Minerva Pediatrica 2020 May;72(3). doi: 10.23736/S0026-4946.20.05887-9.
50. Muris P, Field AP. The role of verbal threat information in the development of childhood fear. “Beware the Jabberwock!” Clinical Child and Family Psychology Review 2010 Jun;13(2):129-50.
51. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KSM, Lau EHY, Wong JY, Xing X, Xiang N, Wu Y, Chao Li, Chen Q, Li D, Liu T, Zhao J, Liu M, Tu W, Chen C, Jin L, Yang R, Wang Q, Zhou S, Wang R, Liu H, Luo Y, Liu Y, Shao G, Li H, Tao Z, Yang Y, Deng Z, Liu B, Ma Z, Zhang Y, Shi G, Lam TTY, Wu JT, Gao GF, Cowling BJ, Yang B, Leung GM, Feng Z. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. The New England Journal of Medicine 2020 Mar;382(13):1199-207.
52. Lee S, Chan LY, Chau AM, Kwok KP, Kleinman A. The experience of SARS-related stigma at Amoy Gardens. Social Science & Medicine (1982) 2005;61(9):2038-46.
53. Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S, Greenberg N, Rubin GJ. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. The Lancet 2020 Mar;395(10227):912-20.
54. Всемирная организация здравоохранения. Антидепрессанты (трициклические антидепрессанты и селективные ингибиторы обратного захвата серотонина) в лечении взрослых людей с депрессией. Доступно по: https://www.who.int/mental_health/mhgap/evidence/depression/q1/ru Ссылка активна на 25.06.2020.
55. National Collaborating Center for Mental Health. Depression. The NICE guideline on the treatment and management of depression in adults. Updated edition. Available from: https://www.nice.org.uk/guidance/cg90/evidence/full-guideline-pdf-4840934509 Accessed 2020 Jun 25.
56. Won E, Park SC, Han KM, Sung SH, Lee HY, Paik JW, Jeon HJ, Lee MS, Shim SH, Ko YH, Lee KJ, Han C, Ham BJ, Choi J, Hwang TY, Oh KS, Hahn SW, Park YC, Lee MS. Evidence-based, pharmacological treatment guideline for depression in Korea, revised edition. Journal of Korean Medical Science 2014 Apr;29(4):468-84.
57. Бауэр М., Пфенниг А., Северус Э., Вайбрау П.С., Ангст Ж., Мюллер Х.-Ю. Клинические рекомендации Всемирной федерации обществ биологической психиатрии по биологической терапии униполярных депрессивных расстройств. Часть 1: Острое и продолженное лечение униполярных депрессивных расстройств по состоянию на 2013 год. Современная терапия психических расстройств 2015;4:33-9.
58. Государственный реестр лекарственных средств. Рег. № П N013622/01. Инструкция по медицинскому применению препарата Золофт®.
59. Janssen DG, Caniato RN, Verster JC, Baune BT. A psychoneuroimmunological review on cytokines involved in antidepressant treatment response. Human Psychopharmacology 2010 Apr;25(3):201-15.
60. Tynan RJ, Weidenhofer J, Hinwood M, Cairns MJ, Day TA, Walker FR. A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia. Brain, Behavior and Immunity 2012;26:469-79.
61. Sitges M, Gómez CD, Aldana BI. Sertraline reduces IL-1β and TNF-α mRNA expression and overcomes their rise induced by seizures in the rat hippocampus. PLoS One 2014 Nov;9(11):e111665.
62. Casey DE. Striking a balance between safety and efficacy: experience with the SSRI sertraline. International Clinical Psychopharmacology 1994 Jun;9(Suppl 3):5-12.
63. Khouzam HR, Emes R, Gill T, Raroque R. The antidepressant sertraline: a review of its uses in a range of psychiatric and medical conditions. Comprehensive Therapy 2003 Spring;29(1):47-53.
64. Edwards JG, Anderson I. Systematic review and guide to selection of selective serotonin re–uptake inhibitors. Drugs 1999 Apr;57(4):507-33.
65. Anderson IM. Meta-analytical studies on new antidepressants. British Medical Bulletin 2001 Mar;57(1):161-78.
66. Geddes JR, Freemantle N, Mason J, Eccles MP, Boynton J. SSRIs versus other antidepressants for depressive disorder. The Cochrane Database of Systemic Reviews 2000;(2):CD 001851.
67. Пантелеева Г.П., Абрамова Л.И., Корнев А.Н. Сравнительная характеристика терапевтической эффективности нового поколения антидепрессантов из группы селективных ингибиторов обратного захвата серотонина. Современная психиатрия, 1998;6:3-7.
68. Шмуклер А.Б. Сертралин: применение в клинической практике. Социальная и клиническая психиатрия 2000;4:101-4.
69. Moon CAL, Wood K, Lane RM, Jago W. Sertraline and clomipramine in mixed anxiety depression. Presented at the British Association for Psychopharmacology; Cambridge, UK; 1993 Jul 25-8.
70. Brady K, Pearlstein T, Asnis GM, Baker D, Rothbaum B, Sikes CR, Farfel GM. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA 2000 Apr;283(14):1837-44.
71. Thompson C. Bridging the gap between psychiatric practice and primary care. International Clinical Psychopharmacology 1992;7(Suppl 2):31-6.
72. Dubey S, Biswas P, Ghosh R, Chatterjee S, Dubey MJ, Chatterjee S, Lahiri D, Lavie CL. Psychosocial impact of COVID-19. Diabetes & Metabolic Syndrome 2020 May 27. doi: 10.1016/j.dsx.2020.05.035. Epub ahead of print.

References

1. Wang C. A novel coronavirus outbreak of global health concern. The Lancet 2020 Feb;395(10223):470-3.
2. Hawryluck L, Gold WL, Robinson S, Pogorski S, Galea S, Styra R. SARS control and psychological effects of quarantine, Toronto, Canada. Emerging Infectious Diseases 2004 Jul;10(7):1206-12.
3. Arciniegas DB, Anderson CA. Viral encephalitis: neuropsychiatric and neurobehavioral aspects. Current Psychiatry Reports 2004 Oct;6(5):372-9.
4. Dubé B, Benton T, Cruess DG, Evans DL. Neuropsychiatric manifestations of HIV infection and AIDS. Journal of Psychiatry & Neuroscience 2005 Jul;30(4):237-46.
5. Hinkin CH, Castellon SA, Atkinson JH, Goodkin K. Neuropsychiatric aspects of HIV infection among older adults. Journal of Clinical Epidemiology 2001 Dec;54(Suppl 1):S44-52.
6. Okusaga O, Yolken RH, Langenberg P, Lapidus M, Arling TA, Dickerson FB, Scrandis DA, Severance E, Cabassa JA, Balis T, Postolache TT. Association of seropositivity for influenza and coronaviruses with history of mood disorders and suicide attempts. Journal of Affective Disorders 2011 Apr;130(1):220-5.
7. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N, Bi Y, Ma X, Zhan F, Wang L, Hu T, Zhou H, Hu Z, Zhou W, Zhao L, Chen J, Meng Y, Wang J, Lin Y, Yuan J, Xie Z, Ma J, Liu WJ, Wang D, Xu W, Holmes EC, Gao GF, Wu G, Chen W, Shi W, Tan W. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet 2020 Feb;395(10224):565-74.
8. Desforges M, Le Coupanec A, Dubeau P, Bourgouin A, Lajoie L, Dubé B, Talbot PJ. Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? Viruses 2020 Jan;12:14.
9. Bohmwald K, Gálvez NMS, Ríos M, Kalergis AM. Neurologic alterations due to respiratory virus infections. Frontiers in Cellular Neuroscience 2018 Oct;12:386.
10. World Health Organization. 2019 novel coronavirus (2019nCoV): strategic preparedness and response plan. Draft, 2020 Feb 03. Geneva, Switzerland: WHO; 2020. 28 p. Available from: https://www.who.int/docs/default-source/coronaviruse/srp-04022020.pdf Accessed 2020 Jun 22.
11. World Health Organization. Mental health and psychosocial considerations during the COVID-19 outbreak. March 18, 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/mental-health-considerations.pdf Accessed 2020 Jun 22.
12. Zhao Q, Hu C, Feng R, Yang Y. Anxiety, depression and somatic symptoms in COVID-19 patients. Chinese Journal of Neurology 2020;53:E003.
13. Cheng SKW, Tsang JSK, Ku KH, Wong CW, Ng YK. Psychiatric complications in patients with severe acute respiratory syndrome (SARS) during the acute treatment phase: a series of 10 cases. The British Journal of Psychiatry 2004 Apr;184:359-60.
14. Chua SE, Cheung V, McAlonan GM, Cheung C, Wong JWS, Cheung EPT, Chan MTY, Wong TKW, Choy KM, Chu CM, Lee PWH, Tsang KWT. Stress and psychological impact on SARS patients during the outbreak. The Canadian Journal of Psychiatry 2004 Jun;49(6):385-90.
15. Cheng SKW, Wong CW, Tsang J, Wong KC. Psychological distress and negative appraisals in survivors of severe acute respiratory syndrome (SARS). Psychological Medicine 2004 Oct;34(7):1187-95.
16. Wu KK, Chan SK, Ma TM. Posttraumatic stress, anxiety, and depression in survivors of severe acute respiratory syndrome (SARS). Journal of Traumatic Stress 2005 Feb;18(1):39-42.
17. Lee AM, Wong J, McAllonan GM, Cheung V, Cheung C, Sham PC, Chu CM, Wong PC, Tsang K, Chua SE. Stress and psychological distress among SARS survivors 1 year after the outbreak. The Canadian Journal of Psychiatry 2007 Apr;52(4):233-40.
18. Mak IWC, Chu CM, Pan PC, Yiu MGC, Chan VL. Long-term psychiatric morbidities among SARS survivors. General Hospital Psychiatry 2009 Jul-Aug;31(4):318-26.
19. Lam MHB, Wing YK, Yu MWM, Leung CM, Ma RCW, Kong APS, So WY, Fong SYY, Lam SP. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Archives of Internal Medicine 2009 Dec;169(22):2142-7.
20. Lin CY, Peng YC, Chang J, Chan CH, Yang DY. The psychological effect of severe acute respiratory syndrome on emergency department staff. Emergency Medicine Journal 2007 Jan;24(1):12-7.
21. Verma S, Mythili S, Chan YH, Deslypere JP, Teo EK, Chong SA. Post-SARS psychological morbidity and stigma among general practitioners and traditional Chinese medicine practitioners in Singapore. Annals of the Academy of Medicine, Singapore 2004 Nov;33(6):743-8.
22. Lancee WJ, Maunder RG, Goldbloom DS; Coauthors for the Impact of SARS study. Prevalence of psychiatric disorders among Toronto hospital workers one to two years after the SARS outbreak. Psychiatric Services (Washington, D.C.) 2008 Jan;59(1):91-5.
23. Liu X, Kakade M, Fuller CJ, Fan B, Fang Y, Kong J, Guan Z, Wu P. Depression after exposure to stressful events: lessons learned from the severe acute respiratory syndrome epidemic. Comprehensive Psychiatry 2012 Jan;53(1):15-23.
24. Ko CH, Yen CF, Yen JY, Yang MJ. Psychosocial impact among the public of the severe acute respiratory syndrome epidemic in Taiwan. Psychiatry and Clinical Neurosciences 2006 Aug;60(4):397-403.
25. Besedovsky H, Rey AD, Sorkin E, Dinarello CA. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science (New York, N.Y.) 1986 Aug;233(4764):652-4.
26. Besedovsky HO, Rey AD, Klusman I, Furukawa H, Monge AG, Kabiersch A. Cytokines as modulators of the hypothalamus-pituitary-adrenal axis. The Journal of Steroid Biochemistry and Molecular Biology 1991;40(4-6):613-8.
27. Wang J, Dunn AJ. Mouse interleukin-6 stimulates the HPA axis and increases brain tryptophan and serotonin metabolism. Neurochemistry International 1998 Aug;33(2):143-54.
28. Licinio J, Wong ML. The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection. Molecular Psychiatry 1999 Jul;4(4):317-27.
29. Capuron L, Fornwalt FB, Knight BT, Harvey PD, Ninan PT, Miller AH. Does cytokine-induced depression differ from idiopathic major depression in medically healthy individuals? Journal of Affective Disorders 2009 Dec;119(1-5):181-5.
30. Vollmer-Conna U. Acute sickness behaviour: an immune system-to-brain communication? Psychological Medicine 2001 Jul;31(5):761-7.
31. Wichers M, Maes M. Psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans. International Journal of Neuropsychopharmacology 2002 Dec;5(4):375-88.
32. Dursun SM, Blackburn JR, Kutcher SP. An exploratory approach to the serotonergic hypothesis of depression: bridging the synaptic gap. Medical Hypotheses 2001 Feb;56(2):235-43.
33. Arbour N, Day R, Newcombe J, Talbot PJ. Neuroinvasion by human respiratory coronaviruses. Journal of Virology 2000 Oct;74(19):8913-21.
34. Dessau RB, Lisby G, Frederiksen JL. Coronaviruses in brain tissue from patients with multiple sclerosis. Acta Neuropathology 2001;101(6):601-4.
35. Fujimoto S, Kobayashi M, Uemura O, Iwasa M, Ando T, Katoh T, Nakamura C, Maki N, Togari H, Wada Y. PCR on cerebrospinal fluid to show influenza-associated acute encephalopathy or encephalitis. The Lancet 1998 Sep;352(9131):873-5.
36. Xu J, Zhong S, Liu J, Li L, Li Y, Wu X, Li Z, Deng P, Zhang J, Zhong N, Ding Y, Jiang Y. Detection of severe acute respiratory syndrome corona virus in the brain: potential role of the chemokine migration in pathogenesis. Clinical Infectious Disease 2005 Oct;41(8):1089-96.
37. Yeh A, Arlene C, Cohen ME, Duffner PK, Faden H. Detection of corona virus in the central nervous system of a child with acute disseminated encephalomyelitis. Pediatrics 2004 Jan;113(1 Pt 1):e73-6.
38. Vindegaard N, Benros ME. COVID-19 pandemic and mental health consequences: systematic review of the current evidence. Brain, Behavioral, and Immunity 2020 May 30. doi: 10.1016/j.bbi.2020.05.048. Epub ahead of print.
39. Bo HX, Li W, Yang Y, Wang Y, Zhang Q, Cheung T, Wu X, Xiang YT. Posttraumatic stress symptoms and attitude toward crisis mental health services among clinically stable patients with COVID-19 in China. Psychological Medicine 2020 Mar 27;1-2. doi: 10.1017/S0033291720000999. Online ahead of print.
40. Zhang J, Lu H, Zeng H, Zhang S, Du Q, Jiang T, Du B. The differential psychological distress of populations affected by the COVID-19 pandemic. Brain, Behavior, and Immunity 2020 Jul;87:49-50.
41. Horton R. Offline: 2019-nCoV – “A desperate plea”. The Lancet 2020 Feb;395:400.
42. Wang C, Pan R, Wan X, Tan Y, Xu L, Ho CS, Ho RC. Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China. International Journal of Environmental Research and Public Health 2020 Mar;17(5):1729.
43. Huang Y, Zhao N. Generalized anxiety disorder, depressive symptoms and sleep quality during COVID-19 outbreak in China: a web-based cross-sectional survey. Psychiatry Research 2020 Jun;288:112954.
44. Su TP, Lien TC, Yang CY, Su YL, Wang JH, Tsai SL, Yin JC. Prevalence of psychiatric morbidity and psychological adaptation of the nurses in a structured SARS Caring Unit during outbreak: a prospective and periodic assessment study in Taiwan. Journal of Psychiatric Research 2007 Jan-Feb;41(1-2):119-30.
45. Hao F, Tan W, Jiang L, Zhang L, Zhao X, Zou Y, Hu Y, Luo X, Jiang X, McIntyre R.S, Tran B, Sun J, Zhang Z, Ho R, Ho C, Tam W. Do psychiatric patients experience more psychiatric symptoms during COVID-19 pandemic and lockdown? A case-control study with service and research implications for immunopsychiatry. Brain, Behavior and Immunity 2020 Apr;87:100-6.
46. Zhu J, Sun L, Zhang L, Wang H, Fan A, Yang B, Li W, Xiao S. Prevalence and influencing factors of anxiety and depression symptoms in the first-line medical staff fighting against COVID-19 in Gansu. Frontiers in Psychiatry 2020;11:386.
47. Zhang WR, Wang K, Yin L, Zhao WF, Xue Q, Peng M, Min BQ, Tian Q, Leng HX, Du JL, Chang HY, Li W, Shangguan FF, Yan TY, Dong HQ, Han Y, Wang YP, Cosci F, Wang HX. Mental health and psychosocial problems of medical health workers during the COVID-19 epidemic in China. Psychotherapy and Psychosomatics 2020 Apr 9;1-9. doi: 10.1159/000507639. Online ahead of print.
48. Wang G, Zhang Y, Zhao J, Zhang J, Jiang F. Mitigate the effects of home confinement on children during the COVID-19 outbreak. The Lancet 2020 Mar;395(10228):945-7.
49. Ghosh R, Dubey MJ, Chatterjee S, Dubey S. Impact of COVID-19 on children: special focus on psychosocial aspect. Minerva Pediatrica 2020 May;72(3). doi: 10.23736/S0026-4946.20.05887-9.
50. Muris P, Field AP. The role of verbal threat information in the development of childhood fear. “Beware the Jabberwock!” Clinical Child and Family Psychology Review 2010 Jun;13(2):129-50.
51. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KSM, Lau EHY, Wong JY, Xing X, Xiang N, Wu Y, Chao Li, Chen Q, Li D, Liu T, Zhao J, Liu M, Tu W, Chen C, Jin L, Yang R, Wang Q, Zhou S, Wang R, Liu H, Luo Y, Liu Y, Shao G, Li H, Tao Z, Yang Y, Deng Z, Liu B, Ma Z, Zhang Y, Shi G, Lam TTY, Wu JT, Gao GF, Cowling BJ, Yang B, Leung GM, Feng Z. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. The New England Journal of Medicine 2020 Mar;382(13):1199-207.
52. Lee S, Chan LY, Chau AM, Kwok KP, Kleinman A. The experience of SARS-related stigma at Amoy Gardens. Social Science & Medicine (1982) 2005;61(9):2038-46.
53. Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S, Greenberg N, Rubin GJ. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. The Lancet 2020 Mar;395(10227):912-20.
54. The World Health Organization. Antidepressants (tricyclic antidepressants and selective serotonin reuptake inhibitors) in treatment of adults with depression. Available from: https://www.who. int/mental_health/mhgap/evidence/depression/q1/ru. Accessed 2020 Jun 25 (In Russian).
55. National Collaborating Center for Mental Health. Depression. The NICE guideline on the treatment and management of depression in adults. Updated edition. Available from: https://www.nice.org.uk/guidance/cg90/evidence/full-guideline-pdf-4840934509 Accessed 2020 Jun 25.
56. Won E, Park SC, Han KM, Sung SH, Lee HY, Paik JW, Jeon HJ, Lee MS, Shim SH, Ko YH, Lee KJ, Han C, Ham BJ, Choi J, Hwang TY, Oh KS, Hahn SW, Park YC, Lee MS. Evidence-based, pharmacological treatment guideline for depression in Korea, revised edition. Journal of Korean Medical Science 2014 Apr;29(4):468-84.
57. Bauer M, Pfennig A, Severus E, Whybrow PS, Angst J, Möller HJ. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders. Part 1. Acute and continuing treatment of unipolar depressive disorders up to 2013. Modern Therapy of Mental Disorders 2015;4:33-9 (In Russian).
58. State register of medicinal products. No P N013622/01. Instructions for medical use of Zoloft®. (In Russian).
59. Janssen DG, Caniato RN, Verster JC, Baune BT. A psychoneuroimmunological review on cytokines involved in antidepressant treatment response. Human Psychopharmacology 2010 Apr;25(3):201-15.
60. Tynan RJ, Weidenhofer J, Hinwood M, Cairns MJ, Day TA, Walker FR. A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia. Brain, Behavior and Immunity 2012;26:469-79.
61. Sitges M, Gómez CD, Aldana BI. Sertraline reduces IL-1β and TNF-α mRNA expression and overcomes their rise induced by seizures in the rat hippocampus. PLoS One 2014 Nov;9(11):e111665.
62. Casey DE. Striking a balance between safety and efficacy: experience with the SSRI sertraline. International Clinical Psychopharmacology 1994 Jun;9(Suppl 3):5-12.
63. Khouzam HR, Emes R, Gill T, Raroque R. The antidepressant sertraline: a review of its uses in a range of psychiatric and medical conditions. Comprehensive Therapy 2003 Spring;29(1):47-53.
64. Edwards JG, Anderson I. Systematic review and guide to selection of selective serotonin re–uptake inhibitors. Drugs 1999 Apr;57(4):507-33.
65. Anderson IM. Meta-analytical studies on new antidepressants. British Medical Bulletin 2001 Mar;57(1):161-78.
66. Geddes JR, Freemantle N, Mason J, Eccles MP, Boynton J. SSRIs versus other antidepressants for depressive disorder. The Cochrane Database of Systemic Reviews 2000;(2):CD 001851.
67. Panteleyeva GP, Abramova LI, Kornev AN. Comparative characteristics of therapeutic efficacy of a new generation of antidepressants from the group of selective serotonin reuptake inhibitors (SSRIs). Modern Psychiatry 1998;6:3-7 (In Russian).
68. Shmukler AB. Sertraline in clinical practice. Social and Clinical Psychiatry 2000;4:101-4 (In Russian).
69. Moon CAL, Wood K, Lane RM, Jago W. Sertraline and clomipramine in mixed anxiety depression. Presented at the British Association for Psychopharmacology; Cambridge, UK; 1993 Jul 25-8.
70. Brady K, Pearlstein T, Asnis GM, Baker D, Rothbaum B, Sikes CR, Farfel GM. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA 2000 Apr;283(14):1837-44.
71. Thompson C. Bridging the gap between psychiatric practice and primary care. International Clinical Psychopharmacology 1992;7(Suppl 2):31-6.
72. Dubey S, Biswas P, Ghosh R, Chatterjee S, Dubey MJ, Chatterjee S, Lahiri D, Lavie CL. Psychosocial impact of COVID-19. Diabetes & Metabolic Syndrome 2020 May 27. doi: 10.1016/j.dsx.2020.05.035. Epub ahead of print.

[ Содержание выпуска N 1 | Выпуски журнала | Список журналов ]